As of May 29, 2025, Tanke Biosciences Corp (TNBI) reports a ROA (Return on Assets) of -0.73%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Tanke Biosciences Corp's ROA (Return on Assets)
Over recent years, Tanke Biosciences Corp's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 2012-12-31 | -0.73% |
| 2011-12-31 | -12.60% |
| 2010-12-31 | 20.64% |
| 2009-12-31 | -2469.33% |
This slight upward trend highlights how Tanke Biosciences Corp manages its efficiency in using assets to generate earnings over time.
Comparing Tanke Biosciences Corp's ROA (Return on Assets) to Peers
To better understand Tanke Biosciences Corp's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Tanke Biosciences Corp (TNBI) | -0.73% |
| Pacific Bepure Industry Inc (PBEP) | 21.23% |
| Hanyuan Biotech International Inc (TNPH) | 20.43% |
| China Skyrise Digital Service Inc (CSKD) | 19.29% |
| Neurobiological Technologies Inc (NTII) | 12.66% |
| Jufeel International Group (CNJG) | 11.38% |
Compared to its competitors, Tanke Biosciences Corp's ROA (Return on Assets) is about average compared to peers, indicating typical asset efficiency for the industry.